Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

Overview of attention for article published in Metabolism: Clinical and Experimental, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy: 1 policy source

twitter: 3 X users

Readers on

mendeley: 60 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 2 policy documents that reference this research output.

Metreleptin for treating lipodystrophy : Final evaluation determination committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 20 Jan 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Metreleptin for treating lipodystrophy : Evaluation consultation committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 10 Jun 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.